This feature examines the impact of pharmacologic interventions on the treatment of the critically ill patient — an area of health care that has become increasingly complex. Recent advances in drug therapy for adult ICU patients (including evolving and controversial data) will be reviewed and assessed in terms of clinical, humanistic, and economic outcomes. Direct questions or comments to Gil Fraser, PharmD, at fraseg@mmc.org.
Get full access to this article
View all access options for this article.
References
1.
FraserG.L., YahwakJ.A., RikerR.R.Corticosteroids in the critically ill.Hosp Pharm.2004; 32: 116–118.
2.
AnnaneD.ICU physicians should abandon the use of etomidate!Intensive Care Med.2005; 31: 325–326.
3.
MalerbaG., Romano-GerardF., CravoisyA.Risk factors of relative adrenocortical deficiency in intensive care patients needing mechanical ventilation.Intensive Care Med.2005; 31: 388–392.
4.
JacksonW.L.JrShould we use etomidate as an induction agent for endotracheal intubation in patients with septic shock?Chest.2005; 127: 1031–1038.
5.
MurrayH., MarikP.E.Etomidate for endotracheal intubation in sepsis.Chest.2005; 127: 707–709.
6.
LuceJ.M.Physicians should administer low-dose corticosteroids selectively to septic patients until an ongoing trial is completed.Ann Intern Med.2004; 141: 70–72.
7.
AnnaneD., BellissantE., BollaertP.E.Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis.BMJ.2004; 329: 480.
8.
ReynoldsS.F., HeffnerJ.Airway management of the critically ill patient.Chest.2005; 127: 1397–1412.
GuldnerG., SchultzJ., SextonP.Etomidate for rapid-sequence intubation in young children: hemodynamic effects and adverse events.Acad Emerg Med.2003; 10: 134–139.
11.
LedinghamI.M., WattI.Influence of sedation on mortality in critically ill multiple trauma patients.Lancet.1983; 1: 1270.
12.
FellowsI.W., BastowM.D., ByrneA.J.Adrenocortical suppression in multiply injured patients: a complication of etomidate treatment.Br Med J. (Clin Res Ed.)1983; 287: 1835–1837.
13.
WagnerR.L., WhiteP.F.Etomidate inhibits adrenocortical function in surgical patients.Anesthesiology.1984; 61: 647–651.
14.
SchenartsC.L., BurtonJ.H., RikerR.R.Adrenocortical dysfunction following etomidate induction in emergency department patients.Acad Emerg Med.2001; 8: 1–7.
15.
AbsalomA., PledgerD., KongA.Adrenocortical function in critically ill patients 24 h after a single dose of etomidate.Anaesthesia.1999; 54: 861–867.
16.
AnnaneD., SebilleV., CharpentierC.Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.JAMA.2002; 288: 862–871.
17.
MokhlesiB.Corticosteroids for patients with septic shock.JAMA.2003; 289: 43–44.
18.
DellingerR.P., CarletJ.M., MasurH.Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.Crit Care Med.2004; 32: 858–873.
19.
HerridgeM.S., CheungA.M., TanseyC.M.One year outcomes in survivors of the acute respiratory distress syndrome.N Engl J Med.2003; 348: 683–693.
20.
ArbousM.S., GrobbeeD.E., van KleefJ.W.Mortality associated with anesthesia: a qualitative analysis to identify risk factors.Anaesthesia.2001; 56: 1141–1153.
